Parkinson's disease DBS: What, when, who and why? The time has come to tailor DBS targets

Expert Review of Neurotherapeutics

Volumn 10, Issue 12, 2010, Pages 1847-1857

  Okun, Michael S ^a   Foote, Kelly D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

candidates; DBS; deep brain stimulation; GPi; Parkinson's disease; STN

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGGRESSIVENESS; ANTICHOLINERGIC EFFECT; BRAIN DEPTH STIMULATION; COGNITION; CONFUSION; DOCTOR PATIENT RELATION; DRUG DOSE REDUCTION; DYSARTHRIA; DYSKINESIA; GENE THERAPY; GLOBUS PALLIDUS; HUMAN; IRRITABILITY; LENGTH OF STAY; MANIA; MOOD; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PATIENT SELECTION; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; SUBTHALAMIC NUCLEUS; SWALLOWING; SYMPTOM; THALAMUS; THALAMUS NUCLEUS; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN; ZONA INCERTA;

DEEP BRAIN STIMULATION; HUMANS; PARKINSON DISEASE; PATIENT CARE TEAM; PATIENT SELECTION; PATIENT-CENTERED CARE; TREATMENT OUTCOME;

EID: 78649508597     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.156     Document Type: Review

References (54)

1. Benabid AL. Deep brain stimulation for Parkinsons disease. Curr. Opin. Neurobiol. 13(6), 696-706 (2003).
2. Benabid AL, Chabardes S, Seigneuret E et al. Functional neurosurgery: past, present, and future. Clin. Neurosurg. 52, 265-270 (2005).
3. Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 355(9), 896-908 (2006).
4. Follett KA, Weaver FM, Stern M et al Pallidal versus subthalamic deep-brain stimulation for Parkinsons disease. N. Engl J. Med. 362(22), 2077-2091 (2010).
5. Weaver FM, Follett K, Stern M et al Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301(1), 63-73 (2009).
6. Williams A, Gill S, Varma T et al Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 9(6), 581-591).
7. Okun MS, Fernandez HH, Wu SS et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann. Neurol. 65(5), 586-595 (2009).
8. Okun MS, Fernandez HH, Rodriguez RL, Foote KD. Identifying candidates for deep brain stimulation in Parkinson's disease: the role of the primary care physician. Geriatrics 62(5), 18-24 (2007).
9. Okun MS, Foote KD. Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? Arch. Neurol. 62(4), 533-536 (2005).
10. Okun MS, Tagliati M, Pourfar M et al Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch. Neurol. 62(8), 1250-1255 (2005).
11. Witt K, Daniels C, Reiff J et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol. 7(7), 605-614 (2008).
12. Zahodne LB, Okun MS, Foote KD et al Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J. Neurol 256(8), 1321-1329 (2009).
13. Hariz MI, Krack P, Alesch F et al Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J. Neurol. Neurosurg Psychiatry 79(6), 694-699 (2008).
14. Okun MS, Vitek JL. Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov. Disord. 19(4), 375-389 (2004).
15. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249(4975), 1436-1438 (1990).
16. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 8(1), 67-81 (2009).
17. Moro E, Hamani C, Poon YY et al Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 133(Pt 1), 215-224 (2010).
18. Stefani A, Lozano AM, Peppe A et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 130(Pt 6), 1596-1607 (2007).
19. Yelnik J. PPN or PPD, what is the target for deep brain stimulation in Parkinson's disease? Brain 130(Pt 9), e79 (2007).
20. Goff LK, Jouve L, Melon C, Salin P. Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson's disease. Parkinsonism Relat. Disord. 15(Suppl. 3), S167-S170 (2009).
21. Plaha P, Khan S, Gill SS. Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J. Neurol Neurosurg Psychiatry 79(5), 504-513 (2008).
22. Taba HA, Wu SS, Foote KD et al. A closer look at unilateral vs bilateral DBS: results of the National Institutes of Health COMPARE cohort. J. Neurosurg DOI: 10.3171/2010.8.JNS10312 (2010) (Epub ahead of print).
23. Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage 47(Suppl. 2), T53-T57 (2009).
24. Mikos A, Pavon J, Bowers D et al. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease. Parkinsonism Relat. Disord. 16(5), 324-328 (2010).
25. Morrell M. Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop seizures? Curr. Opin. Neurol. 19(2), 164-168 (2006).
26. Bronte-Stewart H, Barberini C, Koop MM, Hill BC, Henderson JM, Wingeier B. The STN p-band profle in Parkinsons disease is stationary and shows prolonged attenuation after deep brain stimulation. Exp. Neurol. 215(1), 20-28 (2009).
27. Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 60(1), 78-81 (2003).
28. Okun MS, Foote KD. Enough is enough: moving on to deep brain stimulation in patients with fuctuating Parkinson disease. Arch. Neurol. 66(6), 778-780 (2009).
29. Schupbach WM, Agid Y Psychosocial adjustment after deep brain stimulation in Parkinson's disease. Nat. Clin. Pract. Neurol. 4(2), 58-59 (2008).
30. Schupbach WM, Maltete D, Houeto JL et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 68(4), 267-271 (2007).
31. Haq I, Foote KD, Okun MS. Is earlier better? What do we mean when we advocate for early DBS in Parkinson disease? Appl. Neurol. 24-31 (2008).
32. Charles PD, Gill CE, Davis TL, Konrad PE, Benabid AL. Is deep brain stimulation neuroprotective if applied early in the course of PD? Nat. Clin. Pract. Neurol. 4(8), 424-426 (2008).
33. Okun MS, Foote KD. A mnemonic for Parkinson disease patients considering DBS: a tool to improve perceived outcome of surgery. Neurologist 10(5), 290 (2004).
34. Alberts JL, Hass CJ, Vitek JL, Okun MS. Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease. Exp. Neurol. 214(1), 1-5 (2008).
35. Alberts JL, Okun MS, Vitek JL. The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force control in advanced Parkinson's patients. Parkinsonism Relat. Disord. 14(6), 481-488 (2008).
36. Tabbal SD, Ushe M, Mink JW et al. Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Exp. Neurol. 211(1), 234-242 (2008).
37. Zahodne LB, Okun MS, Foote KD et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change. Clin. Neuropsychol. 23(3), 385-405 (2009).
38. York MK, Dulay M, Macias A et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 79(7), 789-795 (2008).
39. Mikos A, Bowers D, Noecker AM et al. Patient-specifc analysis of the relationship between the volume of tissue activated during DBS and verbal fuency. Neuroimage DOI: 10.1016/j. neuroimage.2010.03.068 (2010) (Epub ahead of print).
40. Burdick AP, Fernandez HH, Foote KD et al. Target specifcity for post-DBS anger. Presented at: Movement Disorders, Movement Disorders Society 14th Annual Congress. Buenos Aires, Argentina, 13-17 June (2010).
41. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 318(5854), 1309-1312 (2007).
42. Ballanger B, van Eimeren T, Moro E et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann. Neurol. 66(6), 817-824 (2009).
43. Alberts JL, Voelcker-Rehage C, Hallahan K, Vitek M, Bamzai R, Vitek JL. Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients. Brain 131(Pt 12), 3348-3360 (2008).
44. Hershey T, Mink J W. Using functional neuroimaging to study the brain's response to deep brain stimulation. Neurology 66(8), 1142-1143 (2006).
45. Hershey T, Wu J, Weaver PM et al. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp. Neurol. 210(2), 402-408 (2008).
46. Okun MS, Fernandez HH, Pedraza O et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology 63(1), 161-163 (2004).
47. Okun MS, Fernandez HH, Foote KD, Murphy TK, Goodman WK. Avoiding deep brain stimulation failures in Tourette syndrome. J. Neurol. Neurosurg. Psychiatry 79(2), 111-112 (2008).
48. Schupbach M, Gargiulo M, Welter ML et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology 66(12), 1811-1816 (2006).
49. Okun MS, Fogel A, Skoblar B et al. Patient centered outcomes for deep BRAIN stimulation. Presented at: 60th Annual Meeting of the American Academy of Neurology. Chicago, IL, USA, 12-19 April (2008).
50. Follett K, Weaver F, Stern M et al. Multisite randomized trial of deep brain stimulation. Arch. Neurol. 62(10), 1643-1644 (2005).
51. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov. Disord. 14(4), 572-584 (1999).
52. Tabbal SD, Revilla FJ, Mink JW et al. Safety and effcacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease. Neurosurgery 61(3 Suppl.), 119-127 (2007).
53. Limousin P, Krack P, Pollak P et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 339(16), 1105-1111 (1998). (Pubitemid 28465758)
54. Voon V, Krack P, Lang AE et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131(Pt 10), 2720-2728 (2008).